Supporting
Information

Resources providing key insights on the competitor landscape, disease awareness, and updates from recent corporate symposiums. Please note that the hub is for internal use only. If you wish to utilise materials included in the hub externally, then the materials must be subject to local legal, medical and regulatory (LMR) review and approval.

Competitors

As you will no doubt be aware, there are many different testosterone therapies licensed and available across the globe that differ in their formulation, route of administration, dosage interval, and safety profile. There is also significant variation in product availability between countries.

A Novel Testosterone 2% Gel for the Treatment of Hypogonadal Males. Journal of Andrology, Vol. 33, No. 4, July/August 2012.
EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISM. ENDOCRINE PRACTICE Vol 23 No. 5 May 2017.

Natesto, a novel testosterone nasal gel, normalizes androgen levels in hypogonadal men. Andrology, 2016, 4, 46–54.

Disease Awareness Adverts

In this section, you will find examples of disease awareness campaigns linked to some of the associated conditions that have been utilised by Besins affiliates.

EAU Symposium

Here you will find a video of the Besins Healthcare Symposium at the EAU 2024 Congress in Paris.

Would you like to receive notification of updates to the Men’s Health Hub?

Registration

You must use a email address.
Submit
Contact Us